IgG receptor polymorphisms: Risk factors for disease

Immunogenetics

Volumn 48, Issue 3, 1998, Pages 222-232

  Van Der Pol, W Ludo ^a   Van De Winkel, Jan G J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Autoimmune disorder; Fc receptor; Infectious disease; Leukocyte; Polymorphism

Indexed keywords

FC RECEPTOR; HEPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; MONOCLONAL ANTIBODY CD3; RECEPTOR SUBTYPE;

AMINO ACID SEQUENCE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; DNA POLYMORPHISM; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; GENETIC RISK; GRAFT REJECTION; HUMAN; IMMUNOTHERAPY; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RECEPTOR AFFINITY; RECEPTOR GENE; REVIEW; SYNCYTIOTROPHOBLAST; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VASCULITIS;

ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; COMMUNICABLE DISEASES; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEPARIN; HUMANS; LEUKOCYTES; LIGANDS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, GENETIC; RECEPTORS, IGG; RISK FACTORS; THROMBOCYTOPENIA; WEGENER GRANULOMATOSIS;

EID: 0031856505     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050426     Document Type: Review

References (109)

1. Abo, T., Tilden, A.B., Balch, C.M., Kumagai, K., Troup, G.M., and Cooper, M.D. Ethnic differences in the lymphocyte proliferative response induced by a murine IgG1 antibody. Leu-4, to the T3 molecule. J Exp Med 160: 303-309, 1984
2. Arepally, G., McKenzie, S.E., Jiang, X.M., Ponez, M., and Cines, D.B. FcγRIIa H/R131 polymorphism, subclass specific antiheparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis. Blood 89: 370-375, 1997
3. Blasini, A.M., Stekman, I.L., Leon-Ponte, M., Caldera, D., and Rodriguez, M.A. Increased proportion of responders to a murine anti-CD3 monoclonal antibody of the IgG1 class in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 94: 423-428, 1993
4. Botto, M., Theodoridis, E., Thompson, E.M., Beynon, H.L.C., Briggs, D., Isenberg, D.A., Walport, M.J., and Davies, K.A. FcγRIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin Exp Immunol 104: 264-268, 1996
5. Brandt, J.T., Isenhart, C.E., Osborne, J.M., and Ahmed, A., and Anderson, C.L. On the role of platelet FcγRIIa phenotype in heparin-induced thrombocytopenia. Thromb Haemost 74: 1564-1572, 1995
6. Bredius, R.G.M., de Vries, C.E.E., Troelstra, A., van Alphen, L., Weening, R.S., van de Winkel, J.G.J., and Out, T.A. Phagocytosis of Staphylococcus aureus and Haemophilus Influenzae type b opsonized with polyclonal human IgG1 and IgG2 antibodies: functional h FcγRIIa polymorphism to IgG2. J Immunol 151: 1463-1472, 1993
7. Bredius, R.G.M., Derkx, B.H.F., Fijen, C.A.P., de Wit, T.P.M., de Haas, M., Weening, R.S., van de Winkel, J.G.J., and Out, T.A. Fcg receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 170: 848-853, 1994a
8. Bredius, R.G.M., Fijen, C.A.P., de Haas, M., Kuijper, E.J., Weening, R.S., van de Winkel, J.G.J., and Out, T.A. Role of the neutrophil FcγRIIa (CD32) and the FcγRIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. Immunology 83: 624-630, 1994b
9. Brooks, D.G., Oiu, W.O., Luster, A.D., and Ravetch, J.V. Structure and expression of human IgG FcRII (CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J Exp Med 170: 1369-1385, 1989
10. Burgess, J.K., Lindeman, R., Chesterman, C.N., and Chong, B.H. Single amino acid mutation of Fγy receptor is associated with the development of heparin-induced thrombocytopenia. Br J Haematol 91: 761-766, 1995
11. Bux, J. and Mueller-Eekhardt, C. Autoimmune neutropenia. Semin Haematol 29: 45-53, 1992
12. Bux, J., Stein, E.L., Bierling, P., Fromont, P., Clay, M.E., Stroncek, D.F.,and Santoso, S. Characterization of a new alloantigen (SH) on the human neutrophil receptor IIIb. Blood 89: 1027-1034, 1997
13. Cambier, J.C. Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine based activation motif (ITAM). J Immunol 155: 3281-3285, 1995
14. Carlsson, L.E., Santoso, S., Baurichter, G., Kroll, H., Papenberg, S., Eichler, P., Westerdaal, N., Kiefel, V., van de Winkel, J.G.J., and Greinacher, A. Heparin-induced thrombocytopenia: New insights into the impact of the FcγRIIa-R-H131 polymorphism. Blood, in press
15. Clark, M.R., Liu, L., Clarkson, S.B., Ory, P.A., and Goldstein, I.M. An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosus. J Clin Invest 86: 341-346, 1990
16. Coremans, I.E.M., Daha, M.R., van der Voort, E.A.M., Siegert, C.E.H., and Breedveld, F.C. Subclass distribution of IgA and IgG antibodies against C1q in patients with rheumatic diseases. Scand J Immunol 41: 391-397, 1995
17. Davies, K.A. Complement, immune complexes and systemic lupus erythematosus. Br J Rheumatol 35: 5-23, 1996
18. De Haas, M., Kleijer, M., Minchinton, R.M., Roos, D., and von dem Borne, A.E.G.Kr. Soluble FcγRIIIa is present in plasma and is derived from Natural Killer cells. J Immunol 152: 900-907, 1994
19. De Haas, M., Kleijer, M., van Zwieten, R., Roos, D., and von dem Borne, A.E.G.Kr. Neutrophil FcγRIIIb deficiency, nature and clinical consequences: a study of 21 individuals from 14 families. Blood 86: 2403-2413, 1995
20. De Haas, M., Koene, H.R., Kleijer, M., de Vries, E., Simsek, S., van Tol, M.J.D., Roos, D., and von dem Borne, A.E.G.Kr. A triallelic Fcγ receptor type IIIa polymorphism influences the binding of human IgG to NK cell FcγRIIIa. J Immunol 156: 2948-2955, 1996
21. Duits, A.J., Bootsma, H., Derksen, R.H.W.M., Spronk, P.E., Kater, L., Kallenberg, C.G.M., Capel, P.J.A., Westerdaal, N.A.C., Spierenburg, G.Th., Gmelig-Meyling, F.H.J., and van de Winkel, J.G.J. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 39: 1832-1836, 1995
22. Edberg, J.C. and Kimberly, R.P. Cell type-specific glycoforms of FcγRIIIa (CD16). Differential ligand binding. J Immunol 159: 3849-3857, 1997.
23. Enenkel, B., Jung, D., and Frey, J. Molecular basis of IgG Fc receptor III defect in a patient with systemic lupus erythematosus. Eur J Immunol 21: 659-663, 1991
24. Fanger, N.A., Wardwell, K., Shen, L., Tedder, T.F., and Guyre, P.M., Type I (CD64) and type II (CD32) Fcγ receptor-mediated phagocytosis by human blood dendritic cells. J Immunol 157: 541-548, 1996
25. Fanger, N.A., Voigtlaender, D., Liu, C., Swink, S., Wardwell, K., Fisher, J., Graziano, R.F., Pfefferkorn, L.C., and Guyre, P.M. Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor FcγRI (CD64) expressed on human blood dendritic cells. J Immunol 158: 3090-3098, 1997
26. Fijen, C.A.P., Bredius, R.G.M., and Kuijper, E.J. Polymorphism of IgG Fc receptors in meningococcal disease Ann Intern Med 119 (letter): 636, 1993
27. Frank, M.M., Hamburger, M.I., Lawley, T.J., Kimberly, R.P., and Plotz, P.H. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 300: 518-523, 1979
28. Fromont, P., Bettaieb, A., Skouri, H., Floch, C., Poulet, E., Duedari, N., and Bierling, P. Frequency of the polymorphonuclear Fcγ receptor III deficiency in the French population and its involvement in the development of neonatal alloimmune neutropenia. Blood 79: 2131-2134, 1992
29. Galon, J., Robertson, M.W., Galinha, A., Mazieres, N., Spagnoli, R., Fridman, W.H., and Sautes, C. Affinity of the interaction between Fc gamma receptor type III (FcγRIII) and monomeric human IgG subclasses. Role of FcγRIII glycosylation. Eur J Immunol 27: 1928-1932, 1997
30. Gavin, A. and Hogarth, P.M. The involvement of human FcγR in altered immunity and disease. In J.G.J. van de Winkel and P.J.A. Capel (eds.): Human IgG Fc Receptors, pp. 195-225, Springer Heidelberg, 1996
31. Gratama, J.W., van der Linden, R., van der Holt, B., Bolhuis, R.L.H., and van de Winkel, J.G.J. Analysis of factors contributing to the formation of mononuclcar cell aggregates ("escapees") in flow cytometric immunophenotyping. Cytometry 29: 250-260, 1997
32. Haagen, I-A., Geerars, A.J.G., Clark, M.R., and van de Winkel, J.G.J. Interaction of human monocyte Fcγ receptors with rat IgG2b. A new indicator for the FcγRIIa (R-H131) polymorphism. J Immunol 154: 1852-1860, 1995
33. Harley, J.B., Sheldon, P., Neas, B., Murphy, S., Wallace, D.J., Scofield, R.H., Shaver, T.S., and Moser, K.L. Systemic lupus erythematosus: considerations for a genetic approach. J Invest Dermatol 103: 144S-149S, 1994
34. Haseley, L.A., Wisnieski, J.J., Denburg, M.R., Michael-Grossman, A.R., Ginzler, E.M., Gourley, M.F., Hoffman, J.H., Kimberly, R.P., and Salmon, J.E. Antibodies to C1q in systemic lupus erythematosus: characteristics and relation to FcγRIIa alleles. Kidney Int 52: 1375-1380, 1997
35. Heijnen, I.A.F.M., van Vugt, M.J., Fanger, N.A., Graziano, R.F., de Wit, T.P.M., Hofhuis, F.M.A., Guyre, P.M., Capel, P.J.A., Verbeck, J.S., and van de Winkel, J.G.J. Antigen targeting to myeloid-specific FcγRI/CD64 triggers enhanced antibody responses in transgenic mice. J Clin Invest 97: 331-338, 1996
36. Hibbs, M.L., Tolvanen, M., and Carpen, O. Membrane-proximal Ig-like domain of FcγRIII (CD16) contains residues critical for ligand binding. J Immunol 152: 4466-4474, 1994
37. Huizinga, T.W.J., van der Schoot, C.E., Jost, C., Klaassen, R., Kleijer, M., von dem Borne, A.E.G.Kr., Roos, D., and Tetleroo, P.A.T. The P1-linked receptor FcRIII is released on stimulation of neutrophils. Nature 333: 667-669, 1988
38. Huizinga, T.W.J., van Kemenade. F., Koenderman, L., Dolman, K.M., von dem Borne, A.E.G.Kr., Tetteroo, P.A.T., and Roos, D. The 40-kDa Fcγ receptor (FcRII) on human neutrophils is essential for the IgG-induced respiratory burst and IgG-induced phagocytosis. J Immunol 142: 2365-2369, 1989
39. Huizinga, T.W.J., Dolman, K.M., van der Linden, N.J.M., Kleijer, M., Nuijens, J.H., von dem Borne, A.E.G.Kr., and Roos, D. Phosphatidylinositol-linked FcRIII mediates exocytosis of neutrophil granule proteins, but does not mediate initiation of the respiratory burst. J Immunol 144: 1432-1437, 1990a
40. Huizinga, T.W.J., de Haas, M., Kleijer, M., Nuijens, J.H., Roos, D., and von dem Borne, A.E.G.Kr. Soluble Fcγ receptor III in human plasma originates from release by neutrophils. J Clin Invest 86: 416-423, 1990b
41. Huizinga, T.W.J., Kleijer, M., Tetteroo, P.A.T., Roos, D., and von dem Borne, A.E.G.Kr. Biallelic neutrophil NA-antigen system is associated with a polymorphism on the phospho-inositol-linked Fcγ receptor III (CD16). Blood 75: 213-217, 1990c
42. Huizinga, T.W.J., de Haas, M., van Oers, M.H.J., Kleijer, M., Vilé, H., van de Wouw, P.A., Moulijn, A., van Weezel, H., Roos, D., and von dem Borne, A.E.G.Kr. The plasma concentration of soluble Fc-gamma-RIII is related to the production of neutrophils. Br J Haematol 87: 459-463, 1994
43. Hulett, M.D., McKenzie, I.F.C., and Hogarth, P.M. Chimeric Fc receptors identify immunoglobulin-binding regions in human FcγRII and FcεRI. Eur J Immunol 23: 640-645, 1993
44. Hulett, M.D., Witort, E., Brinkworth, R.I., McKenzie, I.F.C., and Hogarth, P.M. Identification of the IgG binding site of the human low affinity receptor for IgG. FcγRII. Enhancement and ablation of binding by site-directed mutagenesis. J Biol Chem 269: 15287-15293, 1994
45. Hulett, M.D., Witort, F., Brinkworth, R.I., McKenzie, I.F.C., and Hogarth, P.M. Multiple regions of human FcγRII (CD32) contribute to the binding of IgG. J Biol Chem 270: 21188-21194, 1995
46. Imai, H., Hamai, K., Komatsuda, A., Ohtani, H., and Miura, A.B. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int 51: 270-276, 1997
47. Jefferis, R. and Kumararatne, D.S. Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol 81: 357-367, 1990
48. Junghans, R.P. Finally! The Brambell receptor (FcRB): mediator of transmission of immunity and protection from catabolism for IgG. Immunol Res 16: 29-57, 1997
49. Kelton, J.G., Sheridan, D., Santos, A., Smith, J., Steeves, K., Smith, C., Brown, C., and Murphy, W.G. Heparin induced thrombocytopenia: laboratory studies. Blood 72: 925-930, 1988
50. Kobayashi, T., Westerdaal, N.A.C., Miyazaki, A., van der Pol, W-L., Suzuki, T., Yoshie, H., van de Winkel, J.G.J., and Hara, K. Relevance of immunoglobulin G Fc receptor polymorphism to recurrence of adult periodontilis in Japanese patients. Infect Immun 65: 3556-3560, 1997
51. Kocher, M., Siegel, M.E., Edberg, J.C., and Kimberly, R.P. Cross-linking of Fcγ receptor IIa and Fcγ receptor IIIb induces different proadhesive phenotypes on human neutrophils. J Immunol 159: 3940-3948, 1997
52. Koene, H.R., de Haas, M., Kleijer, M., Roos, D., and von dem Borne, A.E.G.Kr. NA-phenotype dependent differences in neutrophil FcγRIIIb expression cause differences in plasma levels of soluble FcγRIII. Br J Haematol 93: 235-241, 1996
53. Koene, H.R., Kleijer, M., Algra, J., Roos, D., von dem Borne, A.E.G.Kr. and de Haas, M. FcγRIIIa-158 V/F polymorphism influences the binding of IgG by NK cell FcγRIIIa, independently of the FcγRIIIa-48L/R/H phenotype. Blood 90: 1109-1114, 1997
54. Koene, H.R., de Haas, M., Kleijer, M., Huizinga, T.W.J., Roos, D., and von dem Borne, A.E.G.Kr. Clinical value of soluble IgG Fc receptor type III (sFcγRIII) in plasma from patients with neutropenia. Blood 91: 3962-3966, 1998a
55. Koene, H.R., Kleijer, M., Roos, D., de Haas, M., and von dem Borne, A.E.G.Kr. FcγRIIIB gene duplication: evidence for presence and expression of three distinct FcγRIIIB genes in NA(1 + .2 +) SH(+) individuals. Blood 91: 673-679. 1998b
56. Kotzin, B.L. Systemic lupus erythematosus. Cell 85:303-306, 1996.
57. Krauss, J.C., Poo, H., Xue, W., Mayo-Bond, L., Todd III, R.F., and Petty, H.R. Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fcγ receptor IIIb and the complement receptor type 3. J Immunol 153: 1769-1777, 1994
58. Lanier L.L., Yu, G., and Phillips, J.H. Co-associalion of CD3z with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 342: 803-805, 1989
59. Lin, S., Cicala, C., Scharenberg, A.M., and Kinet, J.P. The FceRIb subunit functions as an amplifier of FcεRIg-mediated cell activation signals. Cell 85: 985-995, 1996
60. Liu, C., Goldstein, J., Graziano, R.F., He, J., O'Shea, J.K., Deo, Y., and Guyre, P.M. FcγRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes. J Clin Invest 98: 2001-2007, 1996
61. Liu, Z., Roopenian, D.C., Zhou, X., Christianson, G.J., Diaz, L.A., Sedmak, D.D., and Anderson, C.L. β2-microglobulin-deficient mice are resistant to bullous pemphigoid. J Exp Med 186: 777-783, 1997
62. Manger, K., Repp, R., Spriewald, B.M., Rascu, A., Geiger, A., Wassmuth, R., Westerdaal, N.A.C., Wentz, B., Manger, B., Kalden, J.R., and van de Winkel, J.G.J. FcγRIIa polymorphism in Caucasian patients with systemic lupus erythematosus. Association with clinical symptoms. Arthritis Rheum., in press
63. Masuda, M. and Roos, D. Association of all three types of FcγR (CD64, CD32, and CD16) with a γ-chain homodimer in cultured human monocytes. J Immunol 151: 7188-7195, 1993
64. Miller, K.L., Duchemin, A.M., and Anderson, C.L. A novel role for the Fc receptor γ subunit: enhancement of FcγR ligand affinity. J Exp Med 183: 2227-2233, 1996
65. Morton, H.C., Schiel, A.E., Janssen, S.W.J., and van de Winkel, J.G.J. Alternatively spliced forms of the human myeloid Fcα receptor (CD89) in neutrophils. Immnnogenetics 43: 246-247, 1996
66. Osborne, J.M., Chacko, G.W., Brandt, J.T., and Anderson, C.L. Ethnic variation in frequency of an allelic polymorphism of human FcγRIIa determined with allele specific oligonucleotide probes. J Immunol Methods 173: 207-217, 1994
67. Parlevliet, K.J., ten Berge, I.J.M., Yong, S.L., Surachno, J., Wilmink, J.M., and Schellekens, P.Th.A. In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants. J Clin Invest 93: 2519-2525, 1994
68. Parren, P.W.H.I., Warmerdam, P.A.M., Boeije, L.C.M., Arts. J., Westerdaal, N.A.C., Vlug, A., Capel, P.J.A., Aarden, L., and van de Winkel, J.G.J. On the interaction of IgG subclasses with the low affinity FcγRIIa (CD32) on human monocytes. neutrophils, and platelets. J Clin Invest 90: 1537-1546, 1992a
69. Parren, P.W.H.I., Warmerdam, P.A.M., Boeije, L.C.M., Capel, P.J.A., van de Winkel, J.G.J., and Aarden, L.A. Characterization of IgG FcR-mediated proliferation of human Tcells induced by mouse and human anti-CD3 monoclonal antibodies. Identification of a functional polymorphism to human IgG2 anti-CD3. J Immunol 148: 695-701, 1992b
70. Platonov, A.E., Kuijper, E.J., Vershinina, I.V., Shipulin, G.A., Westerdaal, N.A.C., Fijen, C.A.P., and van de Winkel, J.G.J. Meningococcal disease and polymorphism of FcγRIIa (CD32) in late complement component deficient individuals. Clin Exp Immunol 111: 97-101, 1998
71. Porges, A.J., Redecha, P.B., Kimberly, W.T., Csernok, E., Gross, W.L., and Kimberly, R.P. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via FcγRIIa. J Immunol 153: 1271-1280, 1994
72. Ra, C., Jouvin, M.H.E., Blank, U., and Kinet, J.P. A macrophage Fcγ receptor and the mast cell receptor for IgE share an iden-tical subunit. Nature 341: 752-754, 1989
73. Ralston, D.R., Marsh, C.B., Lowe, M.P., and Wewers, M.D. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of proteinase-3, α1-antitrypsin, and Fcg receptors. J Clin Invest 100: 1416-1424, 1997
74. Rascu, A., Repp, R., Westerdaal, N.A.C., Kalden, J.R., and van de Winkel, J.G.J. Clinical relevance of FcγR polymorphisms. Ann NY Acad Sci 815: 282-295, 1997
75. Ravanel, K., Castelle, C., Defranee, T., Wild, T.F., Charron, D., Lotteau, V., and Rabourdin-Combe, C. Measles virus nucleocapsid protein binds to FcγRII and inhibits human B cell antibody production. J Exp Med 186: 269-278, 1997
76. Ravetch, J.V. and Perussia, B. Alternative membrane forms of FcγRIII (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med 170: 481-197, 1989
77. Salmon, J.E., Edberg, J.C., Brogle, N.L., and Kimberly, R.P. Allelic polymorphisms of human Fcγ receptor IIa and Fcγ receptor IIIb. Independent mechanisms for differences in human phagocyte function. J Clin Invest 89: 1274-1281, 1992
78. Salmon, J.E., Millard, S., Brogle, N.L., and Kimberly, R.P. Fcγ receptor IIIb enhances Fcγ receptor IIa function in an oxidant-dependent and allele-sensitive manner. J Clin Invest 95: 2877-2885, 1995
79. Salmon, J.E., Millard, S., Schachter, L.A., Arnett, F.C., Ginzler, E.M., Gourley, M.F., Ramsey-Goldman, R., Peterson, M.G.E., and Kimberly, R.P. FcγRIIa alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 97: 1348-1354, 1996
80. Sammaritano, L.R., Ng, S., Sobel, R., Kong Lo, S., Simantov, R., Furie, R., Kaell, A., Silverstein, R., and Salmon, J.E. Anticardiolipin IgG subclasses. Association of IgG2 with arterial and/ or venous thrombosis. Arthritis Rheum 411: 1998-2006, 1997
81. Sanders, L.A.M., van de Winkel, J.G.J., Rijkers, G.T., Voorhorst-Ogink, M.M., de Haas, M., Capel, P.J.A., and Zegers, B.J.M. Fcγ receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 170: 848-853, 1994
82. Siegert, C.E.H., Daha, M.R., Tseng, C.M.E.S., Coremans, I.E.M., van Es, L.A., and Breedveld, F.C. Predictive value of IgG autoantibodies against C1q nephritis in systemic lupus erythematosus. Ann Rheum Dis 52: 851-856, 1993.
83. Smyth, L.J.C., Snowden N., Carthy, D., Papasteriades, C., Hajeer, A., and Ollier, W.E.R. FcγRIIa polymorphism in systemic lupus erythematosus. Ann Rheum Dis 56: 744-746, 1997
84. Stockmeyer, B., Valerius, T., Repp, R., Heijnen, I.A.F.M., Bühring, H.J., Deo, Y., Kalden, J.R., Gramatzki, M., and van de Winkel, J.G.J. Preclinical studies with FcγR bispecilic antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer. Cancer Res 57: 696-701, 1997
85. Stuart, S.O., Trounstine, M.L., Vaux, D.J.T., Koch, T., Martens, C.L., Mellman, I., and Moore, K.W. Isolation and expression of cDNA clones encoding a human receptor for IgG (FcγRII). J Exp Med 166: 1668-1684, 1987
86. Sulica, A., Gherman, M., Galatiuc, C., Manciulea, M., and Herberman, R.B. Inhibition of human natural killer activity by cytophilic immunoglobulin G. J Immunol 128: 1031-1036, 1982
87. Takai, T., Li, M., Sylvestre, D., Clynes, R., and Ravetch, J.V. FcR γ chain deletion results in pleitropic effector cell defects. Cell 76: 519-29, 1994.
88. Tamm, A., Kister, A., Nolte, K.U., Gessner, J.E., and Schmidt, R.E. The IgG binding site of human FcγRIIIb receptor involves CC' and FG loops of the membrane-proximal domain J Biol Chem 271: 3659-3666, 1996
89. Tax, W.J.M., Willems, H.W., Reekers, P.P.M., Capel, P.J.A., and Koene, R.A.P. Polymorphism in mitoizenic effect of IgG1 monoclonal antibodies against T3 antigens on human T cells. Nature 304: 445, 1983
90. Tax, W.J.M., Tamboer, W.P.M., Jacobs, C.W.M., Frenken, L.A.M., and Koene, R.A.P. Role of polymorphic Fc receptor FcγRIIa in cytokine release and adverse effects of murine IgG1 anti CD3/T cell receptor antibody (WT31). Transplantation 63: 106-12, 1997
91. Tsao, B.P., Cantor, R.M., Kalunian, K.C., Chen, C.J., Badsha, H., Sirgh, R., Wallace, D.J., Kitridou, R.C., Chen, S., Shen, N., Song, Y.W., Isenberg, D.A., Yu, C.L., Hahn, B.H., and Rotter, J.I. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 90: 725-731, 1997
92. Vance, H.A., Huizinga, T.W.J., Wardwell, K., and Guyre, P.M. Binding of monomeric human IgG defines an expression polymorphism of FcγRIII on large granular lymphocyte/natural killer cells. J Immunol 151: 6429-6439, 1993
93. Van de Winkel, J.G.J. and Capel, P.J.A. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 14: 215-221, 1993
94. Van de Winkel, J.G.J., van Ommen, R., Huizinga, T.W,J. de Raad, M.A.H.V.M., Tuijnman, W.B., Groenen, P.J.T.A., Capel, P.J.A., Koene, R.A.P., and Tax, W.J.M. Proteolysis induces increased binding affinity of the monocyte type II FcR for human IgG. J Immunol 143: 571-578, 1989
95. Van de Winkel, J.G.J., Jansze, M., and Capel, P.J.A. Effect of protease inhibitors on human monocyte IgG Fc receptor II. Evidence that serine esterase activity is essential for FcγRII-mediated binding. J Immunol 145: 1890-1896, 1990
96. Van de Winkel, J.G.J., de Wit, T.P.M., Ernst, L.K., Capel, P.J.A., and Ceuppens, J.L. Molecular basis for a familial defect in the phagocyte expression of IgG Fc receptor I (CD64). J Immunol 154: 2896-2903, 1995
97. Van Vugt, M.J., Heijnen, I.A.F.M., Capel, P.J.A., Park, S.Y., Ra, C., Saito, T., Verbeek, J.S., and van de Winkel, J.G.J. FcR γ-chain is essential for both surface expression and function of human FcγRI (CD64) in vivo. Blood 87: 3593-3599, 1996
98. 2+ response in human neutrophils. J Biol Chem 270: 10671-10679, 1995
99. Vossen, A.C.T.M., Tibbe, G.J.M., Kroos, M.J., van de Winkel, J.G.J., Benner, R., and Savelkoul, H.F.J. Fc receptor binding of anti-CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine-related side effects. Eur J Immunol 25: 1492-96, 1995
100. Wainstein, F., Edberg, J.C., Dow, D., Csemink, E., Sneller, M., Keystone, E., Gross, W., Hofman, G., and Kimberly, R.P. FcγRIIIb alleles are significantly skewed in Wegener's granulomatosis (WG). Arthritis Rheum 38: 1333-1995 (abstract)
101. Warmerdam, P.A.M. van de Winkel, J.G.J., Gosselin, E.J., and Capel, P.J.A. Molecular basis for a polymorphism of human Fcγ receptor II (CD32). J Exp Med 172: 19-25, 1990
102. Warmerdam, P.A.M., van de Winkel, J.G.J., Vlug, A. Wosterdaal, N.A.C., and Capel, P.J.A. A single amino acid in the second Ig-like domain of the human Fcγ receptor II is critical for human IG2 binding. J Immunol 147: 1338-1343, 1991
103. Wilson, M.E. and Kalmar, J.R. FcγRIIa (CD32): a potential marker defining susceptibilily to localized juvenile periodontitis. J Periodontol 67: 323-331, 1996
104. Wirthmueller, U., Kurosaki, T., Murakami, M.S., Ravetch, J.V. Signal transduction by FcγRIII (CD16) is mediated through the g chain. J Exp Med 175: 1381-1390, 1992
105. Wisnieski, J.J. and Jones, S.M. Comparison of autoantibodies to the collagen-like region of C1q in hypoeomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Immunol 148: 1396-1403, 1992
106. 2: CD11b/CD18) restores IgG-dependent phagocytosis in transfectants expressing a phagocytosis-defective FcγRIIa (CD32) tail-minus mutant. J Immunol 157: 5660-5665, 1996
107. Wu, J., Edberg, J.C., Redecha, P.B., Bansal, V., Guyre, P.M., Coleman, K., Salmon, J.E., and Kimberly, R.P. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 100: 1059-1070, 1997
108. Yee, A.M.F., Ng, S.C., Sobel, R.E., and Salmon, J.E. FcγRIIa polymorphism as a risk factor for invasive pneumococcal infections in systemic lupus erythematosus. Arthritis Rheum 40: 1180-1182, 1997
109. 2. CD11b/CD18) and FcγRIII cooperate in generation of a neutrophil respiratory burst: requirement for FcγRII and tyrosine phosphorylation. J Cell Biol 125: 1407-1416, 1994